Objectives Cobalt (Co) exposure is associated with adverse health effects including skin sensitisation, asthma and interstitial lung fibrosis. Exposure to Co in industrial settings is often assessed using air samples or biomonitoring in urine. Skin exposure is rarely measured. Aim of this study was to quantify and compare the importance of Co skin exposure and respiratory exposure in determining urinary Co concentrations.
Methods Co skin exposure was measured in 76 hard metal workers by acid wipe sampling before and at the end of work shifts. Spot urine was collected during a 24-hour period from the start of a shift. Respiratory exposure was measured by personal inhalable dust sampling during a shift in 30 workers. Co was analysed by inductively coupled plasma mass spectrometry.
Results Quantile regression modelling showed that a doubling of Co on skin before or at the end of shift increased the median urinary concentration of Co by 70% (p<0.001) or 32% (p<0.001), respectively. A doubling of Co in air increased median urinary Co by 38% (p<0.001). Co skin exposures were still significantly associated with urinary Co after excluding a group of workers with high respiratory exposure (33%, p=0.021 and 17%, p=0.002).
Conclusions The results indicate an association between Co skin exposure and urinary Co concentrations. This should be considered when using urinary Co as a biomarker of exposure.
- skin exposure
- air exposure
- exposure modeling
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
What is already known about this subject?
Due to the adverse health effects of cobalt (Co), urinary Co as biomarker of Co respiratory exposure is frequently used in occupational settings. The association between skin exposure and urinary excretion of Co is unclear.
What are the new findings?
Urinary Co was demonstrated to be a suitable biomarker for respiratory and skin exposure for a wide exposure range. Skin exposure was shown to be an additional determinant of urinary Co levels.
How might this impact on policy or clinical practice in the foreseeable future?
Skin exposure to Co should not be neglected when using Co in urine as biomarker of exposure.
Cobalt (Co) exposure is associated with adverse health effects including skin sensitisation, asthma, interstitial lung fibrosis and cancer.1–3
Exposure to Co has been reported for hard metal workers, gas turbine and space propulsion workers, base metal refinery workers, dental technicians, construction workers and workers in the electronics industry.4–15 Several exposure studies in occupational settings investigate respiratory exposure, because of the toxicity of Co to the lungs. However, few occupational studies have quantified Co skin exposure in workers.6 10 14 15 Sources of Co skin exposure within the hard metal industry have recently been identified and included the deposition of particles and dust, handling of hard metal items during production as well as touching production equipment and other work materials.16
Urinary Co is frequently used as an exposure biomarker in occupational settings,5 6 15 17–19 due to urine being the primary elimination route of Co after respiratory exposure in humans.20 Several studies have found an association between respiratory exposure and urinary Co in occupationally exposed workers.6 19 21 22 Little is known about the association between skin exposure and urinary excretion of Co, as it has only been studied in a few healthy volunteers.5 6 However, in vitro experiments have shown that metallic Co in particle form can be ionised in synthetic sweat and that Co ions pass through human skin.23 24
There is a lack of studies measuring both respiratory and skin exposure to Co and simultaneously monitoring Co urinary levels, which was the motivation for our study. Our objective was to quantify and compare the importance of skin exposure and air exposure in determining urinary Co concentrations. To achieve this objective, study participants from a hard metal company provided data over a wide range of skin and respiratory exposure levels.
Materials and methods
The study was performed at a hard metal company in Sweden, where both Co powder (micron sized), used as binding agent (concentration 6%–30%) for tungsten carbide to form hard metal alloys (cemented tungsten carbides), and sintered material were handled (see online Supplementary figure S1).
In total, 76 workers were included in the study, of which 58 worked in the production areas and 18 in offices (non-exposed controls). Sampling was performed during 1 week in May and 1 week in August 2013 (at similar climate conditions) during all work shifts. Each worker was sampled during one shift, and the length of the shifts ranged from 5 to 13 hours. Sixty-five workers had been working the day before sampling. Five office workers had been on weekend leave before sampling. For six production workers, we lack information on whether they worked the day before sampling or not. In addition, we gathered information about work tasks performed on the study day, use of gloves and use of respiratory protection.
The study was performed in accordance with the Declaration of Helsinki. Participants provided written informed consent before they were included. At the end of the study, participants received their personal results and were given opportunity to ask questions.
Skin wipe samples were collected at two time points to verify the skin exposure: before the start of the shift, when workers had not changed into their work wear, and at the end of the work shift. In addition, we performed personal 8-hour air sampling and workers collected spot urine samples during 24 hours following the start of shift. For a detailed description of the sampling procedures and methods for analysis, please see our previous publication.10
All plastic appliances used in this study were acid cleaned in 10% nitric acid (HNO3) and rinsed four times with deionised water (16.7 MΩ/cm). All HNO3 was diluted from 65% HNO3 (EMSURE ISO, Merck KGaA, Darmstadt, Germany) in deionised water, unless otherwise specified.
Skin wipe sampling
Co skin exposure was assessed with acid wipe sampling.25 A 2 cm2 skin surface on the volar aspect of the non-dominant index finger was wiped with three consecutive paper wipes moistened with 1% HNO3. Wipes were pooled in a test tube and extracted in 1% HNO3, before chemical analysis of wipe extracts.
Personal respiratory exposure to Co was monitored using a 25 mm filter cassette (Institute of Occupational Medicine inhalable fraction sampler, SKC Ltd, Dorset, UK) mounted in the breathing zone of the worker at flow rate 2.0 L/min, according to EN 481.11 26 27 Air sampling was performed in 30 workers, selected to represent different exposure groups in the production area. We had access to company data on routine air monitoring showing no respiratory exposure to Co in the offices; hence, no air samples were collected for this group.
Midstream spot urine samples of each void (up to 250 mL) were collected by all workers during 24 hours from start of the shift. Each worker received bottles (250 mL, PE-HD, Emballator Mellerud Plast, Sweden) to collect each void separately. All urine samples were stored in a fridge on arrival in the lab. Specific gravity (SG) was measured using a refractometer (Euromex RD 712, Arnhem, the Netherlands) prior to freezing. Mean SG of the urine samples was used to correct for dilution variations in urine samples for the purpose of statistical analyses,28 according to
where Csample is the concentration of Co in the urine sample, SGpop is the mean SG of our study population (1.019 in May, 1.016 in August) and SGsample is the SG of the individual urine sample.
Samples were diluted for chemical analysis as previously described.10 Indium (1 µg/L) and rhodium (5 µg/L) were added as internal standards for acid wipe and urine samples, respectively. Inductively coupled plasma mass spectrometry (Thermo Fisher Scientific iCAP Q, Waltham, Massachusetts, USA) analysis in kinetic energy discrimination mode was used to analyse the intensity of 59Co, 115In and 103Rh in diluted acid wipe extracts and urine samples. A six point calibration curve (0, 0.1, 1, 10, 50, 100 µg/L for acid wipe samples and 0, 0.1, 1, 5, 10, 50 µg/L for urine samples) was made, using matrix-matched calibration standards prepared from dilution of a Co stock solution (996±5 µg/mL; Lot: F2-CO02044, Spectrascan, Teknolab AS, Norway) in 1% HNO3 (analysis grade) for acid wipe extracts and in a diluted urine matrix for urine analysis.10
Limit of detection (LOD) for Co (three times the SD of the method blanks) ranged between 0.015 µg/L and 0.027 µg/L for acid wipe sample analysis and between 0.041 and 0.098 µg/L for urine sample analysis (LOD uncorrected for SG). For quality control purposes, Seronorm Trace Elements L-1 (LOT. 1403080) and L-2 (LOT. 1403081) (SERO AS, Billingstad, Norway) were used as reference material for urine analysis (see online Supplementary table S1).
Collected air samples were analysed by an International Organisation for Standardisation certified laboratory at Örebro University Hospital. The method for air filter preparation before analysis has been described elsewhere.10 LOD of the filter analysis was 0.007 µg/L for Co. STAMI filters (A4-0089 and A4-0116, National Institute of Occupational Health, Oslo, Norway) were used as reference material for quality control.
All four variables contained outliers and measures below the LOD. Median and range were therefore used to describe Co skin exposure before shift (SB-Co), at end of shift (SE-Co), in air (A-Co) and in urine (U-Co).
We evaluated associations between A-Co and either SB-Co or SE-Co with the Spearman’s rank correlation coefficient. Differences in exposure across different groups were verified with the Wilcoxon rank-sum test.
We used log-transformed data for further statistical analysis, because distribution of all four variables was right skewed. Quantile regression was used to verify differences in log-transformed U-Co across groups. Furthermore, we performed quantile regression to evaluate the association between the dependent variable U-Co and the independent exposure variables. Quantile regression is similar to linear regression.29 30 The main difference is that the former estimates any quantile of interest (eg, median, quartiles) of the outcome variable, while the latter estimates its mean. The quantile regression method permitted inclusion of all the available values, without having to impute measures below the LOD, and it was robust to the outlying values and marked skewness of the outcome variable. All logarithms were to base 2, because this facilitated interpretation of the observed ratio being the factor by which the dependent variable (U-Co) is multiplied following a doubling of the covariate(s) (SB-Co, SE-Co and/or A-Co) included in the model.
We estimated three univariable regression models (1, 2 and 3) and two bivariable models (4 and 5). In model 1.1 and 1.2, the logarithm of SB-Co was the only covariate, whereas in model 2.1 and 2.2 the only covariate was logarithm of SE-Co. In model 3, logarithm of A-Co was the only covariate. In model 4, both the logarithm of SB-Co and A-Co were included as covariates, and model 5 included the logarithm of SE-Co and A-Co as covariates. In model 1.2 and 2.2, workers with high A-Co were excluded, thereby keeping the influence of air exposure on U-Co in these models as low as possible.
Departures from linearity on the log-scale were tested by introducing splines. The 95% CIs are reported along with the point estimates. Because the measures were taken repeatedly on the same individuals, we estimated the SEs of the regression coefficient with 500 design-matrix bootstrap samples. All the analyses were performed in Stata V.14.
Co on skin
Skin exposures of Co before (SB-Co) and at end of shift (SE-Co) for the four groups are shown in table 2. The Wilcoxon rank-sum test was performed to evaluate if skin exposures (µg/cm2) were different between the groups at both time points for sampling (table 2).
Analysis showed that working with raw material resulted in a significantly higher median SB-Co (0.096 µg/cm2; p<0.001) compared with all other groups. Median SB-Co in sintered material, final product and control groups did not differ from each other (0.013, 0.014 and 0.012 µg/cm2, respectively).
Median SE-Co was significantly lower in the control group compared with all other groups (0.012 µg/cm2; p≤0.001). The raw material group had significantly higher median SE-Co than all other groups (0.86 µg/cm2; p<0.001). Differences in median SE-Co between the groups working with sintered material (0.046 µg/cm2) and the final product (0.12 µg/cm2) were not statistically significant.
Co in air
Thirty air samples were collected, of which 13 belonged to the raw material, nine to the final product and eight to the sintered material groups. Two air samples of raw material workers were excluded from statistical analysis, since the workers wore respiratory protective equipment. Air samples from the breathing zone did therefore not represent their exposure. Working with raw materials gave rise to statistically significantly higher A-Co (median 5.6 µg/m3; p<0.001) compared with sintered materials (median 0.13 µg/m3) and final product (median 0.14 µg/m3), tested with the Wilcoxon rank-sum test (table 3).
Co in urine
In total, 563 urine samples were collected, and on average seven (range 4–11) samples per person (table 4). Overall U-Co in samples above LOD ranged between 0.038 and 31 µg/L. The only group with statistically significantly higher U-Co was raw material (median 1.8, range 0.13–31 µg/L; p<0.001), tested with design-matrix bootstrapped quantile regression (table 4). No difference could be found between the other three groups.
Correlation between S-Co and A-Co
Spearman’s rank correlation showed that A-Co correlated well with SE-Co (rs=0.801; p<0.001) and to a lower degree with SB-Co (rs=0.448; p<0.001).
Using quantile regression, we could not find a significant change over time in U-Co related to exposure during the 24-hour period (online Supplementary figure S2).
In model 1.1, we used 76 individual pairs of SB-Co and U-Co to evaluate the effect of SB-Co on U-Co with quantile regression. There was a significant association, with an observed ratio of 1.70 (95% CI 1.51 to 1.91, p<0.001) (figure 1B and online Supplementary table S3). In model 1.2, the effect of SB-Co on U-Co was evaluated again, however, now excluding all raw material workers (52 individual pairs). The observed ratio was 1.33 (95% CI 1.04 to 1.70, p=0.021) (online Supplementary table S3).
Using SE-Co in model 2.1 with all 76 individual pairs, the observed ratio was 1.32 (95% CI 1.17 to 1.49, p<0.001) (figure 1C and online Supplementary table S3), whereas excluding all raw material workers in model 2.2, the observed ratio was 1.17 (95% CI 1.06 to 1.30, p=0.002) (online Supplementary table S3).
In model 3, we evaluated the effect of A-Co on the workers’ U-Co. The 46 pairs that were used in this model included 28 A-Co samples monitored in this study (table 3) and an imputed A-Co value for the 18 workers in the control group (0.010 µg/m3). This value was assigned based on comparison with cobalt concentrations measured in air samples of the production workers in our study. The value was lower than the lowest value of Co concentration measured in production areas (0.012 µg/m3) and equal to the 1/2000 of the Swedish OEL indicating negligible respiratory exposure. The observed ratio between A-Co and U-Co was 1.38 (95% CI 1.25 to 1.54, p<0.001) (figure 1A and online Supplementary table S3).
In model 4, we showed the effect of SB-Co and A-Co together on U-Co (46 individual pairs). The observed ratio for SB-Co was 1.27 (95% CI 0.94 to 1.71, p=0.118), whereas the ratio for A-Co was 1.31 (95% CI 1.13 to 1.52, p<0.001) (online Supplementary table S3). Model 5 showed the effect of SE-Co and A-Co together on U-Co (46 individual pairs). This provided an observed ratio for SE-Co that was 0.98 (95% CI 0.84 to 1.14, p=0.784), whereas the ratio for A-Co was 1.42 (95% CI 1.19 to 1.70, p<0.001) (online Supplementary table S3).
To our knowledge, this is the largest study conducted to analyse the association between Co skin and respiratory exposure and urinary Co. Our findings confirmed skin and respiratory exposure of hard metal workers to Co as determinants of urinary Co concentration over a wide range of skin exposures (0.00059–135 µg/cm2) and respiratory exposures (0.012–24 µg/m3). Conversely, we did not find a time-dependent fluctuation in urinary Co concentrations that was related to Co exposure on the study day.
A weakness of this study is that air samples were not collected for all workers, although the data was enough to elucidate the association between A-Co and U-Co. Considering that SB-Co and SE-Co were strongly correlated with A-Co, our study may have lacked sufficient statistical power when assessing the joint contribution of these exposures on U-Co in the quantile regression model. Nevertheless, when the contribution of skin exposure was analysed in only workers mainly exposed on skin, the association of SB-Co and SE-Co with U-Co was still significant, indicating that skin exposure should not be neglected in these occupational settings.
Interestingly, we observed a stronger association between U-Co and SB-Co than between U-Co and SE-Co, irrespective of excluding raw material workers in the analysis. After the shift, the skin was normally cleaned; however, residues of the skin exposure may remain,6 31 32 thereby causing a continuous, low-dose exposure as reflected in the SB-Co values. Since we had no information about whether and how long before the end of shift workers had washed their hands, this may have attenuated the results in the models using SE-Co.
Our study was performed during a regular work day without prior vacation which can be considered a strength, as the results are comparable to everyday working circumstances. We did not find any time-dependent fluctuation in urinary Co concentration related to Co exposure during the studied shift, which has also been observed by other researchers.33 Urinary excretion of Co after respiratory exposure may range from hours to weeks or years.20 34 Furthermore, urinary excretion after Co skin exposure has only been studied twice in healthy volunteers, and excretion reached a maximum within 24 hours.5 6 Some researchers have proposed a spot urine sample at the end of shift at the end of a work week as the optimal sampling strategy for biological monitoring of Co.5 6 19 21 However, recently published data revealed that exposure misclassification was likely if relying on a single spot urine sample.35 A strength of our study is that we used multiple spot urine samples, thereby reducing the risk of exposure misclassification.
Co deposited on skin can contribute to urinary Co levels via skin absorption, as indicated in in vitro studies using human skin23 24 and the above-mentioned reasoning regarding urinary excretion in human volunteers.5 6 In addition, oral exposure may have contributed to Co in urine by hand-to-mouth activities which were not monitored in our study design. However, the employer required the workers to wash their hands before smoking or eating. The impact of this is difficult to evaluate since only 10 workers in our study were smokers. Linnainmaa and Kiilunen showed that smoking and intake of vitamin B12 have small to no influence on urinary Co concentrations.6 This probably relates to the fact that faeces is the primary excretion route following oral administration.20
Our study was not designed to elucidate between oral exposure by hand-to-mouth activity or skin absorption, but only to assess the possible associations between skin exposures and urinary levels of Co to emphasis the importance of monitoring skin exposure.
Many studies have demonstrated the usefulness of Co in urine or blood as biomarkers of Co respiratory exposure.5 6 15 17–19 21 33 Urine5 6 and blood15 have only been used as biomarker for skin exposure in a few studies. In this study, urinary Co was used as biomarker of both exposure routes. It is a non-invasive method, and Co levels are usually higher in urine compared with blood, which makes them easier to detect.
Urinary Co was demonstrated to be a suitable biomarker for multiple exposure routes for a wide exposure range. Considering the significant associations in our analysis, we can conclude that Co skin exposure can be used as an additional determinant of urinary Co concentrations. This should be taken into consideration when using urine as a biomarker of respiratory exposure—the approach of the global hard metal industry today. More studies are needed to determine if Co is absorbed through skin and thereby contributing to urinary Co concentrations or if other factors are also relevant.
We thank Lennart Lundgren and Lizbet Skare for their help with sampling at the hard metal industry. Bernt Bergström and Carin Pettersson at Örebro University Hospital are acknowledged for chemical analysis of air samples. We acknowledge Professor Inger Odnevall Wallinder and Gunilla Herting at the Division of Surface and Corrosion Science, Royal Institute of Technology (KTH) in Stockholm for performing preliminary sample analysis. We would also like to thank the hard-metal company and its employees for participating in the study.
Contributors KM, CL and AJ applied for funding, ethical permission and designed the study. JK, KM and AJ prepared and performed the sampling and evaluated data. JK and KM performed the chemical analysis. JK, AJ and MB performed statistical analysis and interpreted the result and drafted the manuscript. All authors contributed to improving the manuscript and approved the final version.
Funding This study was financially supported by the Swedish Research Council for Health, Working Life and Welfare (Forte, research grants no 2012-1105 and 2009-1765).
Competing interests None declared.
Patient consent Not required.
Ethics approval The regional ethical review board in Stockholm (dnr 2012/1802-31/1).
Provenance and peer review Not commissioned; externally peer reviewed.